COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,944 Articles (22,604 medRxiv, 8,340 bioRxiv)

Most recent first Previous |  Page 2740: Articles 27391-27400  | Next

COVID-19 Healthcare Demand Projections: Arizona
Gel, E., Jehn, M., Lant, T., Muldoon, A., Nelson, T., Ross, H. M.
10.1101/2020.05.13.20099838 — Posted: 2020-05-16
Adjusted fatality rates of COVID19 pandemic: a comparison across countries
Canelo-Aybar, C., Beltran, J., Santero, M., Alonso-Coello, P.
10.1101/2020.05.13.20099796 — Posted: 2020-05-16
Multilevel Integrated Model with a Novel Systems Approach (MIMANSA) for Simulating the Spread of COVID-19
Welling, A. A., Patel, A. P., Kulkarni, P. S., Vaidya, V. G.
10.1101/2020.05.12.20099291 — Posted: 2020-05-16
Country differences in hospitalisation, length of stay and admission to Intensive Care Units due to SARS-CoV-2 infection: a rapid review of available literature
Lane, E. A., Barrett, D. J., Casey, M., McAloon, C. G., Collins, A. B., Hunt, K., Byrne, A. W., McEvoy, D., Barber, A., Griffin, J. M., Wall, P., More, S. J.
10.1101/2020.05.12.20099473 — Posted: 2020-05-16
Relaxing lockdown measures in epidemic outbreaks using selective socio-economic containment with uncertainty
Albi, G., Pareschi, L., Zanella, M.
10.1101/2020.05.12.20099721 — Posted: 2020-05-16
The first 100 days of SARS-CoV-2 control in Vietnam
Pham, T. Q., Rabaa, M., Duong, L. H., Dang, T. Q., Tran, Q. D., Quach, H. L., Hoang, N. A., Phung, D. C., Ngu, N. D., Tran, A. T., La, N. Q., Tran, M. P., Vinh, C., Nguyen, K. C., Dang, D. A., Tran, D. N., Thwaites, G. E., van Doorn, H. R., Choisy, M., OUCRU COVID-19 Research Group
10.1101/2020.05.12.20099242 — Posted: 2020-05-16
Improved survival outcome in SARs-CoV-2 (COVID-19) Acute Respiratory Distress Syndrome patients with Tocilizumab administration
Wadud, N., Ahmed, N., Mannu Shergil, M., Khan, M., Krishna, M. G., Gilani, A., El Zarif, S., Galaydick, J., Linga, K., Koor, S., Galea, J., Stuczynski, L., Osundele, M. B.
10.1101/2020.05.13.20100081 — Posted: 2020-05-16
COVID-19 in Spain: age, Interleukin-6, C Reactive Protein and lymphocytes as key clues from a multicentre retrospective study
Jurado, A., Martin, M. C., Abad-Molina, C., Orduna, A., Martinez, A., Ocana, E., Yarce, O., Navas, A. M., Trujillo, A., Fernandez-Pereira, L., Vergara, E., Rodriguez, B., Quirant, B., Martinez, E., Hernandez, M., Perurena, J., Gil, J., Cantenys, S., Gonzalez-Martinez, G., Martinez-Saavedra, M. T., Rojo, R., Marco, F. M., Mora, S., Ontanon, J., Lopez-Hoyos, M., Ocejo-Vinyals, G., Melero, J., Aguilar, M., Almeida, D., Medina, S., Vegas, M. C., Jimenez, Y., Prada, A., Monzon, D., Boix, F., Cunil, V., Molina, J.
10.1101/2020.05.13.20101345 — Posted: 2020-05-16
Modeling Tempo of COVID-19 Pandemic in India and Significance of Lockdown
Singh, B. P., Singh, G.
10.1101/2020.05.15.20103325 — Posted: 2020-05-16
Estimation of the true infection rate and infection fatality rate of COVID-19 in the whole population of each country
Sonoo, M., Kanbayashi, T., Shimohata, T., Kobayashi, M., Hayashi, H.
10.1101/2020.05.13.20101071 — Posted: 2020-05-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).